<?xml version="1.0" encoding="UTF-8"?>
<p>Secondary endpoints included adherence to antiviral therapy in the group of PWIDs treated according to the concept of DOT, the frequency of early termination of therapy and the occurrence rate of serious adverse events.</p>
